Aligos Therapeutics, Inc. SC 13G and SC 13G/A reports

Location
One Corporate Dr., 2 Nd Floor, South San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
9/14/2024, 04:07 AM
Form type Sec Links Description Filing date Reporting date
SC 13G Report Sep 12, 2024
SC 13G/A Report Feb 14, 2024
SC 13G/A Report ALIGOS THERAPEUTICS, INC. Feb 14, 2024
SC 13G/A Report SC 13G/A Feb 14, 2024
SC 13G/A Report AMENDMENT NO. 2 Feb 14, 2024
SC 13G Report Feb 14, 2024
SC 13G Report Feb 14, 2024
SC 13G/A Report SC 13G/A Nov 7, 2023
SC 13G Report Nov 2, 2023
SC 13G/A Report ALIGOS THERAPEUTICS, INC. Feb 14, 2023
SC 13G/A Report AMENDMENT NO. 1 Feb 14, 2023
SC 13G/A Report Feb 13, 2023
SC 13G/A Report JHG PLC OWNS <5% Feb 9, 2023
SC 13G/A Report SC 13G/A Feb 8, 2023
SC 13G Report Dec 27, 2022
SC 13G Report Feb 14, 2022
SC 13G/A Report Feb 14, 2022
SC 13G Report SCHEDULE 13G Feb 14, 2022
SC 13G/A Report ALIGOS THERAPEUTICS, INC. Feb 14, 2022
SC 13G Report JANUS HENDERSON GROUP PLC OWNS 5.7% OF ALIGOS CIK 0001799448 Feb 14, 2022
SC 13G/A Report SC 13G/A Feb 10, 2022
SC 13G/A Report SC 13G/A Feb 10, 2022
SC 13G/A Report SEC SCHEDULE 13G Feb 10, 2022
SC 13G/A Report SEC SCHEDULE 13G Feb 4, 2022
SC 13G/A Report SEC SCHEDULE 13G Feb 4, 2022
SC 13G Report Aug 13, 2021
SC 13G Report ALIGOS THERAPEUTICS, INC. Feb 16, 2021
SC 13G Report SC 13G Feb 16, 2021
SC 13G Report SC 13G Feb 11, 2021
SC 13G Report SC 13G Feb 11, 2021
SC 13G Report SEC SCHEDULE 13G Jan 11, 2021
SC 13G Report SCHEDULE 13G Oct 28, 2020
SC 13G Report SEC SCHEDULE 13G Oct 22, 2020